492 related articles for article (PubMed ID: 23955458)
21. [Successful diagnosis of lymphoplasmacytic lymphoma with IgG paraprotein using MYD88 L265P mutation analysis].
Abe M; Saburi M; Itani K; Kohno K; Soga Y; Kondo Y; Kawano Y; Nakayama T
Rinsho Ketsueki; 2018; 59(6):695-697. PubMed ID: 29973445
[TBL] [Abstract][Full Text] [Related]
22. Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm.
Shekhar R; Naseem S; Binota J; Varma N; Malhotra P
Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):231-239. PubMed ID: 33217360
[TBL] [Abstract][Full Text] [Related]
23. MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.
Poulain S; Boyle EM; Roumier C; Demarquette H; Wemeau M; Geffroy S; Herbaux C; Bertrand E; Hivert B; Terriou L; Verrier A; Pollet JP; Maurage CA; Onraed B; Morschhauser F; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
Br J Haematol; 2014 Nov; 167(4):506-13. PubMed ID: 25160558
[TBL] [Abstract][Full Text] [Related]
24. Highly sensitive
Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G; Zaccaria GM; Omedè P; Passera R; Orsucci L; Benevolo G; Cavallo F; Galimberti S; Sanz RG; Boccadoro M; Ladetto M; Ferrero S
Haematologica; 2018 Jun; 103(6):1029-1037. PubMed ID: 29567768
[TBL] [Abstract][Full Text] [Related]
25. Gamma heavy chain disease lacks the MYD88 L265p mutation associated with lymphoplasmacytic lymphoma.
Hamadeh F; MacNamara S; Bacon CM; Sohani AR; Swerdlow SH; Cook JR
Haematologica; 2014 Sep; 99(9):e154-5. PubMed ID: 24859878
[No Abstract] [Full Text] [Related]
26. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.
Swerdlow SH; Kuzu I; Dogan A; Dirnhofer S; Chan JK; Sander B; Ott G; Xerri L; Quintanilla-Martinez L; Campo E
Virchows Arch; 2016 Mar; 468(3):259-75. PubMed ID: 26454445
[TBL] [Abstract][Full Text] [Related]
27. L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.
Mori N; Ohwashi M; Yoshinaga K; Mitsuhashi K; Tanaka N; Teramura M; Okada M; Shiseki M; Tanaka J; Motoji T
PLoS One; 2013; 8(11):e80088. PubMed ID: 24224040
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.
Varettoni M; Arcaini L; Zibellini S; Boveri E; Rattotti S; Riboni R; Corso A; Orlandi E; Bonfichi M; Gotti M; Pascutto C; Mangiacavalli S; Croci G; Fiaccadori V; Morello L; Guerrera ML; Paulli M; Cazzola M
Blood; 2013 Mar; 121(13):2522-8. PubMed ID: 23355535
[TBL] [Abstract][Full Text] [Related]
29. Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis.
Wang W; Lin P
Pathology; 2020 Jan; 52(1):6-14. PubMed ID: 31767130
[TBL] [Abstract][Full Text] [Related]
30. Improved accuracy of discrimination between IgM multiple myeloma and Waldenström macroglobulinaemia by testing for MYD88 L265P mutations.
Willenbacher W; Willenbacher E; Brunner A; Manzl C
Br J Haematol; 2013 Jun; 161(6):902-4. PubMed ID: 23560587
[No Abstract] [Full Text] [Related]
31. Composite monoclonal B-cell lymphocytosis and MYD88 L265P-positive lymphoplasmacytic lymphoma in a patient with IgM light chain amyloidosis: Case report.
Oishi N; Inoue T; Odate T; Mochizuki K; Ohashi K; Kirito K; Kondo T
Pathol Int; 2020 Jul; 70(7):458-462. PubMed ID: 32323419
[TBL] [Abstract][Full Text] [Related]
32. Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis.
Rossi D
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):113-8. PubMed ID: 25696843
[TBL] [Abstract][Full Text] [Related]
33. Preneoplastic somatic mutations including
Rodriguez S; Celay J; Goicoechea I; Jimenez C; Botta C; Garcia-Barchino MJ; Garces JJ; Larrayoz M; Santos S; Alignani D; Vilas-Zornoza A; Perez C; Garate S; Sarvide S; Lopez A; Reinhardt HC; Carrasco YR; Sanchez-Garcia I; Larrayoz MJ; Calasanz MJ; Panizo C; Prosper F; Lamo-Espinosa JM; Motta M; Tucci A; Sacco A; Gentile M; Duarte S; Vitoria H; Geraldes C; Paiva A; Puig N; Garcia-Sanz R; Roccaro AM; Fuerte G; San Miguel JF; Martinez-Climent JA; Paiva B
Sci Adv; 2022 Jan; 8(3):eabl4644. PubMed ID: 35044826
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS.
Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez de Villambrosia S; Gomez Mediavilla A; Urquieta Lam M; Insunza A; Tonda R; Beltran S; Gut M; Gonzalez A; Montes-Moreno S
J Clin Pathol; 2020 Sep; 73(9):571-577. PubMed ID: 31980558
[TBL] [Abstract][Full Text] [Related]
35. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y
Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.
Alley CL; Wang E; Dunphy CH; Gong JZ; Lu CM; Boswell EL; Burchette J; Lagoo AS
Arch Pathol Lab Med; 2013 Apr; 137(4):503-17. PubMed ID: 23544940
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.
Treon SP; Cao Y; Xu L; Yang G; Liu X; Hunter ZR
Blood; 2014 May; 123(18):2791-6. PubMed ID: 24553177
[TBL] [Abstract][Full Text] [Related]
38. Low-grade B-cell lymphoma presenting primarily in the bone marrow.
Iwatani K; Takata K; Sato Y; Miyata-Takata T; Iwaki N; Cui W; Sawada-Kitamura S; Sonobe H; Tamura M; Saito K; Miyatani K; Yamasaki R; Yamadori I; Fujii N; Terasaki Y; Maeda Y; Tanimoto M; Nakamura N; Yoshino T
Hum Pathol; 2014 Jul; 45(7):1379-87. PubMed ID: 24767771
[TBL] [Abstract][Full Text] [Related]
39. Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells.
Sewastianik T; Guerrera ML; Adler K; Dennis PS; Wright K; Shanmugam V; Huang Y; Tanton H; Jiang M; Kofides A; Demos MG; Dalgarno A; Patel NA; Nag A; Pinkus GS; Yang G; Hunter ZR; Jarolim P; Munshi NC; Treon SP; Carrasco RD
Blood Adv; 2019 Nov; 3(21):3360-3374. PubMed ID: 31698464
[TBL] [Abstract][Full Text] [Related]
40. VS38 staining contributes to a novel gating strategy in flow cytometry for small B cell lymphoma, especially in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
Mizuta S; Yamane N; Mononobe S; Watanabe A; Matsuki S; Komai T; Koba Y; Mitani S; Kawata T; Tamekane A; Watanabe M
Cytometry B Clin Cytom; 2022 Jan; 102(1):50-61. PubMed ID: 33682304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]